Blockchain Registration Transaction Record
Elicio Therapeutics Makes Strides in Cancer Vaccination Industry
Elicio Therapeutics (NASDAQ: ELTX) achieves key milestones in cancer vaccination industry with its AMP platform and ELI-002 vaccine, contributing to the growth of the global cancer vaccine market. Learn more about the company's groundbreaking immunotherapy advancements and their potential impact on cancer treatment outcomes.
![Elicio Therapeutics Makes Strides in Cancer Vaccination Industry](/_next/image?url=https%3A%2F%2Fpublic.newsdirect.com%2F827161781%2F0eKicokv.png&w=640&q=75)
The advancements made by Elicio Therapeutics in cancer immunotherapy, specifically with the development of the AMP platform and the promising results of ELI-002, have significant implications for patients facing limited treatment options and poor outcomes. The growing global cancer vaccine market also reflects a shift towards increased awareness and investment in cancer vaccination, potentially offering hope for better treatment outcomes and improved quality of life for cancer patients.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x73196dfe19f406c877ca057d9e848b22d821a1061c32b441f9b3f85c55d1e3ca |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | rendSbFr-3223bf6f11e6851a6780c2dfff85aa47 |